Xbrane Biopharma AB (publ) (STO:XBRANE)
Sweden flag Sweden · Delayed Price · Currency is SEK
12.70
+0.15 (1.20%)
Oct 13, 2026, 1:47 PM CET

Xbrane Biopharma AB Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2622102462972,2582,624
Market Cap Growth
-60.34%-14.54%-17.28%-86.83%-13.94%58.03%
Enterprise Value
2761173863712,1332,285
Last Close Price
12.5510.2020.101250.0010262.5013100.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-1.65----
Forward PE
-2.4518.4027.7413.1820.01
PS Ratio
3.101.381.661.2539.19245.04
PB Ratio
0.480.381.181.745.326.08
P/TBV Ratio
0.480.381.181.745.326.08

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
3.280.772.601.5637.03213.37

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.120.100.921.350.090.10
Net Debt / Equity Ratio
0.03-0.050.320.97-0.37-0.58
Net Debt / EBITDA Ratio
-0.231.44-0.92-0.581.071.46
Net Debt / FCF Ratio
-0.110.11-0.50-0.400.761.01
Asset Turnover
0.130.200.200.360.080.02
Inventory Turnover
0.370.280.102.59--
Quick Ratio
0.712.430.400.421.021.84
Current Ratio
3.197.121.131.412.172.55
Return on Equity (ROE)
-16.02%-12.00%-74.40%-108.02%-39.34%-53.15%
Return on Assets (ROA)
-5.83%-1.65%-6.88%-27.60%-13.84%-19.14%
Return on Capital Employed (ROCE)
-10.70%-3.20%-27.00%-90.80%-33.60%-37.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-29.00%60.54%-108.25%-130.56%-7.64%-7.18%
FCF Yield
-50.43%-119.28%-54.58%-139.07%-9.10%-9.42%
Buyback Yield / Dilution
97.34%-67.03%-4184.59%-12.26%-8.38%-30.25%